Canopy Growth Corporation (CGC) vs Kyverna Therapeutics, Inc. (KYTX)
A side-by-side comparison of Canopy Growth Corporation and Kyverna Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGC
Canopy Growth Corporation
$0.89HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
KYTX
Kyverna Therapeutics, Inc.
$6.21HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — CGC vs KYTX
growth of $100 · dividends reinvested · last 3yCGC -80.8% (-42.3%/yr)KYTX -78.9% (-40.5%/yr)KYTX compounded faster over this window
CGC KYTX
CGC vs KYTX: by the numbers
- •KYTX is the larger company ($378M vs $376M market cap).
- •Both run net losses; KYTX's is the smaller (0.00% vs -81.04% net margin).
Metrics side by side
Valuation
| Metric | CGC | KYTX |
|---|---|---|
| P/S ratio | 1.63 | N/A |
| P/B ratio | 0.78 | 2.28 |
Profitability
| Metric | CGC | KYTX |
|---|---|---|
| Gross margin | 25.47% | 0.00% |
| Operating margin | -31.98% | 0.00% |
| Net margin | -81.04% | 0.00% |
| ROE | -38.57% | -92.20% |
| ROIC | -10.85% | -80.67% |
Growth (annualized)
| Metric | CGC | KYTX |
|---|---|---|
| Revenue CAGR (5Y) | -12.47% | N/A |
| Total return CAGR (5Y) | -63.36% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.